Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 12 |
GO:0043226 | organelle | 2 | 12 |
GO:0043227 | membrane-bounded organelle | 3 | 12 |
GO:0043229 | intracellular organelle | 3 | 12 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:0016020 | membrane | 2 | 2 |
Related structures:
AlphaFold database: Q4Q409
Term | Name | Level | Count |
---|---|---|---|
GO:0000075 | cell cycle checkpoint signaling | 4 | 2 |
GO:0000077 | DNA damage checkpoint signaling | 5 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006259 | DNA metabolic process | 4 | 2 |
GO:0006281 | DNA repair | 5 | 2 |
GO:0006325 | chromatin organization | 4 | 12 |
GO:0006479 | protein methylation | 4 | 12 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0006950 | response to stress | 2 | 2 |
GO:0006974 | DNA damage response | 4 | 2 |
GO:0007165 | signal transduction | 2 | 2 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0008213 | protein alkylation | 5 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0010564 | regulation of cell cycle process | 5 | 2 |
GO:0010948 | negative regulation of cell cycle process | 6 | 2 |
GO:0016043 | cellular component organization | 3 | 12 |
GO:0016570 | histone modification | 5 | 12 |
GO:0016571 | histone methylation | 5 | 12 |
GO:0018022 | peptidyl-lysine methylation | 5 | 12 |
GO:0018193 | peptidyl-amino acid modification | 5 | 12 |
GO:0018205 | peptidyl-lysine modification | 6 | 12 |
GO:0019538 | protein metabolic process | 3 | 12 |
GO:0031570 | DNA integrity checkpoint signaling | 5 | 2 |
GO:0032259 | methylation | 2 | 12 |
GO:0033554 | cellular response to stress | 3 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0034729 | histone H3-K79 methylation | 7 | 12 |
GO:0034968 | histone lysine methylation | 6 | 12 |
GO:0035556 | intracellular signal transduction | 3 | 2 |
GO:0036211 | protein modification process | 4 | 12 |
GO:0042770 | signal transduction in response to DNA damage | 4 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043412 | macromolecule modification | 4 | 12 |
GO:0043414 | macromolecule methylation | 3 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 12 |
GO:0045786 | negative regulation of cell cycle | 5 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0048519 | negative regulation of biological process | 3 | 2 |
GO:0048523 | negative regulation of cellular process | 4 | 2 |
GO:0050789 | regulation of biological process | 2 | 12 |
GO:0050794 | regulation of cellular process | 3 | 12 |
GO:0050896 | response to stimulus | 1 | 2 |
GO:0051098 | regulation of binding | 3 | 2 |
GO:0051101 | regulation of DNA binding | 4 | 2 |
GO:0051716 | cellular response to stimulus | 2 | 2 |
GO:0051726 | regulation of cell cycle | 4 | 12 |
GO:0065007 | biological regulation | 1 | 12 |
GO:0065009 | regulation of molecular function | 2 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0071840 | cellular component organization or biogenesis | 2 | 12 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 12 |
GO:1901987 | regulation of cell cycle phase transition | 6 | 2 |
GO:1901988 | negative regulation of cell cycle phase transition | 7 | 2 |
GO:2000677 | regulation of transcription regulatory region DNA binding | 5 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0008168 | methyltransferase activity | 4 | 12 |
GO:0008170 | N-methyltransferase activity | 5 | 12 |
GO:0008276 | protein methyltransferase activity | 3 | 12 |
GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 5 | 12 |
GO:0016278 | lysine N-methyltransferase activity | 6 | 12 |
GO:0016279 | protein-lysine N-methyltransferase activity | 4 | 12 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 12 |
GO:0018024 | obsolete histone lysine N-methyltransferase activity | 5 | 12 |
GO:0031151 | histone H3K79 methyltransferase activity | 6 | 12 |
GO:0042054 | histone methyltransferase activity | 4 | 12 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 217 | 219 | PF00675 | 0.299 |
CLV_NRD_NRD_1 | 86 | 88 | PF00675 | 0.628 |
CLV_PCSK_KEX2_1 | 149 | 151 | PF00082 | 0.339 |
CLV_PCSK_KEX2_1 | 88 | 90 | PF00082 | 0.651 |
CLV_PCSK_PC1ET2_1 | 149 | 151 | PF00082 | 0.339 |
CLV_PCSK_PC1ET2_1 | 88 | 90 | PF00082 | 0.721 |
CLV_PCSK_SKI1_1 | 105 | 109 | PF00082 | 0.300 |
CLV_PCSK_SKI1_1 | 149 | 153 | PF00082 | 0.348 |
CLV_PCSK_SKI1_1 | 89 | 93 | PF00082 | 0.699 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.532 |
DOC_CYCLIN_RxL_1 | 86 | 94 | PF00134 | 0.714 |
DOC_MAPK_gen_1 | 127 | 136 | PF00069 | 0.305 |
DOC_MAPK_gen_1 | 161 | 167 | PF00069 | 0.479 |
DOC_MAPK_gen_1 | 177 | 185 | PF00069 | 0.258 |
DOC_MAPK_gen_1 | 231 | 238 | PF00069 | 0.637 |
DOC_MAPK_MEF2A_6 | 127 | 136 | PF00069 | 0.305 |
DOC_MAPK_MEF2A_6 | 179 | 187 | PF00069 | 0.349 |
DOC_PP1_RVXF_1 | 103 | 109 | PF00149 | 0.342 |
DOC_USP7_UBL2_3 | 219 | 223 | PF12436 | 0.411 |
DOC_WW_Pin1_4 | 17 | 22 | PF00397 | 0.609 |
LIG_14-3-3_CanoR_1 | 231 | 236 | PF00244 | 0.581 |
LIG_Actin_WH2_2 | 134 | 151 | PF00022 | 0.203 |
LIG_BRCT_BRCA1_1 | 155 | 159 | PF00533 | 0.411 |
LIG_BRCT_BRCA1_1 | 189 | 193 | PF00533 | 0.266 |
LIG_BRCT_BRCA1_2 | 155 | 161 | PF00533 | 0.331 |
LIG_deltaCOP1_diTrp_1 | 241 | 248 | PF00928 | 0.488 |
LIG_EVH1_2 | 21 | 25 | PF00568 | 0.612 |
LIG_FHA_1 | 200 | 206 | PF00498 | 0.281 |
LIG_FHA_1 | 74 | 80 | PF00498 | 0.537 |
LIG_LIR_Nem_3 | 10 | 16 | PF02991 | 0.583 |
LIG_LIR_Nem_3 | 245 | 251 | PF02991 | 0.505 |
LIG_PCNA_PIPBox_1 | 29 | 38 | PF02747 | 0.668 |
LIG_Pex14_2 | 187 | 191 | PF04695 | 0.315 |
LIG_Pex14_2 | 238 | 242 | PF04695 | 0.599 |
LIG_SH2_CRK | 13 | 17 | PF00017 | 0.724 |
LIG_SH2_NCK_1 | 155 | 159 | PF00017 | 0.331 |
LIG_SH2_SRC | 249 | 252 | PF00017 | 0.510 |
LIG_SH2_STAP1 | 155 | 159 | PF00017 | 0.331 |
LIG_SH2_STAT5 | 249 | 252 | PF00017 | 0.448 |
LIG_SH2_STAT5 | 3 | 6 | PF00017 | 0.656 |
LIG_SH3_3 | 24 | 30 | PF00018 | 0.578 |
LIG_SUMO_SIM_anti_2 | 180 | 188 | PF11976 | 0.331 |
LIG_TRAF2_1 | 143 | 146 | PF00917 | 0.411 |
LIG_TYR_ITIM | 153 | 158 | PF00017 | 0.331 |
LIG_TYR_ITIM | 31 | 36 | PF00017 | 0.679 |
LIG_UBA3_1 | 79 | 88 | PF00899 | 0.535 |
MOD_CK2_1 | 157 | 163 | PF00069 | 0.331 |
MOD_CK2_1 | 39 | 45 | PF00069 | 0.649 |
MOD_CK2_1 | 91 | 97 | PF00069 | 0.589 |
MOD_Cter_Amidation | 85 | 88 | PF01082 | 0.540 |
MOD_GlcNHglycan | 112 | 115 | PF01048 | 0.328 |
MOD_GSK3_1 | 153 | 160 | PF00069 | 0.362 |
MOD_GSK3_1 | 181 | 188 | PF00069 | 0.371 |
MOD_GSK3_1 | 91 | 98 | PF00069 | 0.645 |
MOD_N-GLC_2 | 117 | 119 | PF02516 | 0.266 |
MOD_NEK2_1 | 123 | 128 | PF00069 | 0.266 |
MOD_NEK2_1 | 16 | 21 | PF00069 | 0.573 |
MOD_NEK2_1 | 187 | 192 | PF00069 | 0.283 |
MOD_NEK2_1 | 225 | 230 | PF00069 | 0.522 |
MOD_NEK2_1 | 91 | 96 | PF00069 | 0.583 |
MOD_NEK2_2 | 226 | 231 | PF00069 | 0.470 |
MOD_PIKK_1 | 95 | 101 | PF00454 | 0.631 |
MOD_PK_1 | 5 | 11 | PF00069 | 0.650 |
MOD_Plk_1 | 49 | 55 | PF00069 | 0.622 |
MOD_Plk_4 | 181 | 187 | PF00069 | 0.290 |
MOD_ProDKin_1 | 17 | 23 | PF00069 | 0.609 |
MOD_SUMO_for_1 | 178 | 181 | PF00179 | 0.309 |
MOD_SUMO_rev_2 | 124 | 129 | PF00179 | 0.331 |
MOD_SUMO_rev_2 | 217 | 225 | PF00179 | 0.411 |
TRG_DiLeu_BaLyEn_6 | 27 | 32 | PF01217 | 0.670 |
TRG_ENDOCYTIC_2 | 13 | 16 | PF00928 | 0.699 |
TRG_ENDOCYTIC_2 | 155 | 158 | PF00928 | 0.411 |
TRG_ENDOCYTIC_2 | 33 | 36 | PF00928 | 0.560 |
TRG_ER_diArg_1 | 230 | 233 | PF00400 | 0.610 |
TRG_NES_CRM1_1 | 110 | 121 | PF08389 | 0.266 |
TRG_Pf-PMV_PEXEL_1 | 218 | 222 | PF00026 | 0.280 |
TRG_Pf-PMV_PEXEL_1 | 34 | 38 | PF00026 | 0.668 |
TRG_Pf-PMV_PEXEL_1 | 89 | 93 | PF00026 | 0.725 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IMC9 | Leptomonas seymouri | 77% | 84% |
A0A0S4JJM1 | Bodo saltans | 46% | 74% |
A0A1X0P3M1 | Trypanosomatidae | 52% | 100% |
A0A3S5H7U7 | Leishmania donovani | 98% | 100% |
A0A422N3B5 | Trypanosoma rangeli | 52% | 100% |
A4HLN9 | Leishmania braziliensis | 92% | 100% |
A4I974 | Leishmania infantum | 98% | 100% |
D0A6D6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 48% | 91% |
E9B415 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
V5B8S7 | Trypanosoma cruzi | 51% | 100% |